Compare HOMB & SHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HOMB | SHC |
|---|---|---|
| Founded | 1998 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.7B | 5.2B |
| IPO Year | 2006 | 2020 |
| Metric | HOMB | SHC |
|---|---|---|
| Price | $30.00 | $16.63 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 10 |
| Target Price | ★ $32.88 | $21.44 |
| AVG Volume (30 Days) | 1.7M | ★ 2.5M |
| Earning Date | 10-14-2026 | 11-03-2026 |
| Dividend Yield | ★ 3.07% | N/A |
| EPS Growth | 19.90 | ★ 68.75 |
| EPS | ★ 1.84 | 0.48 |
| Revenue | N/A | ★ $1,163,617,000.00 |
| Revenue This Year | $4.28 | $6.90 |
| Revenue Next Year | $3.19 | $5.48 |
| P/E Ratio | ★ $16.29 | $33.91 |
| Revenue Growth | N/A | ★ 5.74 |
| 52 Week Low | $25.50 | $13.09 |
| 52 Week High | $31.70 | $19.85 |
| Indicator | HOMB | SHC |
|---|---|---|
| Relative Strength Index (RSI) | 53.05 | 41.14 |
| Support Level | $29.70 | $14.93 |
| Resistance Level | $30.49 | $18.58 |
| Average True Range (ATR) | 0.56 | 0.62 |
| MACD | -0.02 | -0.08 |
| Stochastic Oscillator | 31.52 | 27.75 |
Home BancShares Inc is a bank holding company that operates through its wholly owned community bank subsidiary, Centennial Bank. The bank provides a broad range of commercial and retail banking, as well as related financial services, to a diverse customer base. Its customer base includes businesses, real estate developers and investors, individuals, and municipalities. The company's loan portfolio, while diversified, is typically between half and two thirds in commercial real estate loans. The company's plan emphasizes growth, both through strategic acquisitions and organically within its existing markets. The company has one reportable segment: The Banking Segment.
Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical, and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three reportable segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment, which generates maximum revenue, provides outsourced terminal sterilization and irradiation services for medical devices, pharmaceuticals, food safety, and other application markets using three core technologies: gamma irradiation, EO processing, and E-beam irradiation. Geographically, the company generates maximum revenue from the United States, followed by Canada, Europe, and other regions.